Previous studies have demonstrated that CD4+ T cells infiltration of the diseased nodes is a potential predictive indicator of overall survival (OS) and event-free survival (EFS) in DLBCL patients receiving R-CHOP (Keane et al., 2013). The gene discussed is CD4; the disease is diffuse large B-cell lymphoma.